Diasorin
DiaSorin S.p.A., headquartered in Italy, is a prominent player in the global diagnostics industry, specialising in the development and production of innovative diagnostic solutions. Founded in 1968, the company has established a strong presence in major operational regions, including Europe, North America, and Asia.
With a focus on immunodiagnostics and molecular diagnostics, DiaSorin offers a range of unique products, including its LIAISON® and Simplexa™ platforms, which are renowned for their accuracy and efficiency. The company has achieved significant milestones, such as expanding its product portfolio and enhancing its technological capabilities, solidifying its market position as a leader in the field.
Recognised for its commitment to quality and innovation, DiaSorin continues to advance healthcare diagnostics, making a meaningful impact on patient care worldwide.
+23 vs industry average
Diasorin’s score of 61 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Diasorin?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Diasorin's reported carbon emissions
In 2025, DiaSorin reported total carbon emissions of approximately 106,000,000 kg CO2e, comprising 4,184,000 kg CO2e from Scope 1, 12,807,000 kg CO2e from Scope 2, and 96,847,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming for Net Zero emissions by 2050. Additionally, DiaSorin projects a near-term reduction of 18.52% in carbon emissions, targeting approximately 305,010,000 kg CO2e by 2028. This commitment encompasses all scopes of emissions, reflecting a proactive approach to climate action. The emissions data is sourced directly from DiaSorin S.p.A., with no cascaded data from parent organizations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Diasorin’s Climate Goals (2030 & 2050)
2 goals2028
52% reduction in all scopes
We project that carbon emissions will decrease over the next five years to 305,01 tCO2e by 2028. This is a reduction of 18,52%.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Diasorin
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project